ECSP982809A - Forma termodinamicamente estable del acido (r)-3-[[(4- fluorofenil) sulfonil] amino]- 1,2,3,4,-tetrahidro-9h- carbazol-9-propanoico (ramatroban) - Google Patents

Forma termodinamicamente estable del acido (r)-3-[[(4- fluorofenil) sulfonil] amino]- 1,2,3,4,-tetrahidro-9h- carbazol-9-propanoico (ramatroban)

Info

Publication number
ECSP982809A
ECSP982809A ECSP982809A ECSP982809A EC SP982809 A ECSP982809 A EC SP982809A EC SP982809 A ECSP982809 A EC SP982809A EC SP982809 A ECSP982809 A EC SP982809A
Authority
EC
Ecuador
Prior art keywords
thermodynamically stable
ramatroban
stable form
fluorofenil
sulfonil
Prior art date
Application number
Other languages
English (en)
Inventor
Alfons Grunenberg
Karl-Heinz Wahl
Klaus-Peter Voges
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982809 priority Critical patent/ECSP982809A/es
Publication of ECSP982809A publication Critical patent/ECSP982809A/es

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se relaciona con una modificación termodinámicamente estable del compuesto activo ramatroban. La forma termodinámicamente estable se prepara mediante la fusión de la forma metaestable y subsiguiente recristalización o sembrando una solución del compuesto activo metaestable con un cristal para sembrar de la forma termodinámicamente estable. El compuesto activo termodinámicamente estable puede ser empleado como un agente para el asma.
ECSP982809 1998-12-24 1998-12-24 Forma termodinamicamente estable del acido (r)-3-[[(4- fluorofenil) sulfonil] amino]- 1,2,3,4,-tetrahidro-9h- carbazol-9-propanoico (ramatroban) ECSP982809A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982809 ECSP982809A (es) 1998-12-24 1998-12-24 Forma termodinamicamente estable del acido (r)-3-[[(4- fluorofenil) sulfonil] amino]- 1,2,3,4,-tetrahidro-9h- carbazol-9-propanoico (ramatroban)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982809 ECSP982809A (es) 1998-12-24 1998-12-24 Forma termodinamicamente estable del acido (r)-3-[[(4- fluorofenil) sulfonil] amino]- 1,2,3,4,-tetrahidro-9h- carbazol-9-propanoico (ramatroban)

Publications (1)

Publication Number Publication Date
ECSP982809A true ECSP982809A (es) 1999-06-01

Family

ID=42043726

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982809 ECSP982809A (es) 1998-12-24 1998-12-24 Forma termodinamicamente estable del acido (r)-3-[[(4- fluorofenil) sulfonil] amino]- 1,2,3,4,-tetrahidro-9h- carbazol-9-propanoico (ramatroban)

Country Status (1)

Country Link
EC (1) ECSP982809A (es)

Similar Documents

Publication Publication Date Title
BR0112693A (pt) (derivados) de ácido sulfonilaminometilbenzóico substituìdos e processo para preparação do mesmo
NO20006221L (no) Fremgangsmåte for bekjempelse av skadedyr
BR0317421A (pt) Géis de fase única não-aquosa estável e formulações destes para liberação a partir de um dispositivo implantável
RS50008B (sr) Antifungalna oralna kompozicija koja sadrži itrakonazol i postupak za dobijanje iste
TWI255807B (en) Therapeutic agents
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
MXPA03010435A (es) Derivados de oxazol acido carboxilico sustituidos para uso como activadores de proliferacion del peroximosa(ppar-alfa y gama) en el tratamiento de diabetes.
MY140638A (en) New heterocyclic compounds, which are active as inhibitors of beta-lactamases
PE20011371A1 (es) Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5
WO2004055005A8 (en) Novel compounds having selective inhibiting effect at gsk3
SE0202463D0 (sv) Novel compounds
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
BR0015836A (pt) Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
SG165162A1 (en) Modified release pharmaceutical formulation
UY27886A1 (es) Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco.
AU3850600A (en) Dalda analogs and their use
DK1339412T3 (da) Formulering, som indeholder phosphatderivater af elektronoverførselsmidler
SE9701304D0 (sv) Compounds
UA72895C2 (uk) Нова кристалічна модифікація n торасеміду
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
GT199800198A (es) Formatermodinamicamenteestabledelacido(r)-3-[[(4-fluorofenil)sulfonil]amino]-1,2,3,4-tetrahidro-9h-carbazol-9-propanoico(ramatroban ).
SE9803773D0 (sv) Compounds
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof